Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niccola Funel

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Biomatter|December 9, 2014
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer modelsClaudio Ricci, Carlos Mota, Stefania Moscato, et al.
Molecules (Basel, Switzerland)|January 10, 2026
Synthesis and Application of a Glucoconjugated Organometallic Rhenium Complex as an IR Imaging Probe for Glycolytic Cancer CellsGiulia Bononi, Erica Paltrinieri, Serena Fortunato, et al.
Annals of Surgery|November 6, 2018
Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal AdenocarcinomaLaura L Meijer, Ingrid Garajová, Chiara Caparello, et al.
Langenbeck'S Archives of Surgery|August 25, 2016
Robotic pancreatoduodenectomy with vascular resectionEmanuele F Kauffmann, Niccolò Napoli, Francesca Menonna, et al.
Clinical Epigenetics|December 18, 2015
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapyIngrid Garajová, Niccola Funel, Michelangelo Fiorentino, et al.
World Journal of Gastroenterology|September 10, 2016
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancerChiara Caparello, Laura L Meijer, Ingrid Garajova, et al.
Cancers|March 19, 2020
A Model of a Zebrafish Avatar for Co-Clinical TrialsAlice Usai, Gregorio Di Franco, Patrizia Colucci, et al.
Pharmaceutical Research|May 25, 2012
Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinomaOrazio Vittorio, Giuseppe Cirillo, Francesca Iemma, et al.
Pharmacogenomics|December 7, 2018
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancerEleonora Rofi, Caterina Vivaldi, Marzia Del Re, et al.
Biochemical Pharmacology|May 13, 2019
Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell lineNele Van Der Steen, Alessandro Leonetti, Kaylee Keller, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Biomatter|December 9, 2014
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer modelsClaudio Ricci, Carlos Mota, Stefania Moscato, et al.
Molecules (Basel, Switzerland)|January 10, 2026
Synthesis and Application of a Glucoconjugated Organometallic Rhenium Complex as an IR Imaging Probe for Glycolytic Cancer CellsGiulia Bononi, Erica Paltrinieri, Serena Fortunato, et al.
Annals of Surgery|November 6, 2018
Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal AdenocarcinomaLaura L Meijer, Ingrid Garajová, Chiara Caparello, et al.
Langenbeck'S Archives of Surgery|August 25, 2016
Robotic pancreatoduodenectomy with vascular resectionEmanuele F Kauffmann, Niccolò Napoli, Francesca Menonna, et al.
Clinical Epigenetics|December 18, 2015
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapyIngrid Garajová, Niccola Funel, Michelangelo Fiorentino, et al.
World Journal of Gastroenterology|September 10, 2016
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancerChiara Caparello, Laura L Meijer, Ingrid Garajova, et al.
Cancers|March 19, 2020
A Model of a Zebrafish Avatar for Co-Clinical TrialsAlice Usai, Gregorio Di Franco, Patrizia Colucci, et al.
Pharmaceutical Research|May 25, 2012
Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinomaOrazio Vittorio, Giuseppe Cirillo, Francesca Iemma, et al.
Pharmacogenomics|December 7, 2018
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancerEleonora Rofi, Caterina Vivaldi, Marzia Del Re, et al.
Biochemical Pharmacology|May 13, 2019
Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell lineNele Van Der Steen, Alessandro Leonetti, Kaylee Keller, et al.
Pageof 10